CSIMarket Company Name, Ticker, Competitors, else..
 
Emmaus Life Sciences Inc   (EMMAW)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 64
 Employees 33
 Revenues (TTM) (Millions $) 12
 Net Income (TTM) (Millions $) -7
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Business Description


Emmaus Life Sciences Inc is a biopharmaceutical company that focuses on the development and commercialization of innovative treatments for rare and orphan diseases. The company is best known for their flagship product, Endari, which is an oral powder indicated for the treatment of sickle cell disease. Endari is the first FDA-approved treatment for sickle cell disease in nearly 20 years. Emmaus Life Sciences Inc is committed to improving the lives of patients with rare diseases through their research, development, and commercialization efforts.


   Company Address: 21250 Hawthorne Boulevard Torrance 90503 CA
   Company Phone Number: 214‑0065   Stock Exchange / Ticker: EMMAW


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BMRN        2.88% 
CORT   -1.98%    
RARE   -40.26%    
SRPT        7.86% 
TEVA   -0.22%    
VTRS        3.3% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.03
Working Capital Ratio 0.11
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.12 $
Revenues (TTM) 0.19 $
Cash Flow (TTM) 0.01 $
Cash 0.03 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 368,667
Net Income per Employee (TTM) -217,091
Receivable Turnover Ratio (TTM) 5.09
Inventory Turnover Ratio (TTM) 0.48
Asset Turnover Ratio (TTM) 0.54

Profitability Ratios Current
Gross Margin (MRQ) 93.9 %
Operating Margin (MRQ) 19.73 %
Net Margin (MRQ) -50.65 %
Net Cash Flow Margin (MRQ) 32.24 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Emmaus Life Sciences Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.